Iloprost
伊洛前列素
Report date: 2026/05/20 20:02:01
NME
Base Information
Drug NameIloprost
Drug Alias Name +[19]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[21]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2003/09/15
Country/Territory +[15]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHamad Medical CorporationCharite University, Berlin, GermanyNational Cancer Institute +[6]
Inactive CompaniesShanghai Jiao Tong University School of MedicineLudwig Maximilians University Of MunichEicos Sciences Inc +[11]
Active Indications +[9]
Inactive Indications +[12]